Abstract
Background: Measuring tumor response to treatment is important for both clinical decision-making and multi-institutional studies. There are two radiographic assessment criteria of treatment response for thymic epithelial tumors (TET): Response Evaluation Criteria In Solid Tumors version 1.1 (RECIST 1.1) and International Thymic Malignancy Interest Group (ITMIG) modified criteria. This study was to compare these two assessment criteria for TET treated with chemoradiotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
